Impacts of sarcopenia on prostate cancer patients undergoing docetaxel chemotherapy

被引：0
|
作者：
Lin, Jacky [1 ]
Tyler, Gemma [1 ]
Linker, Joshua [1 ]
Shen, Dennis [1 ]
Zwan, Benjamin [2 ]
Ho, Nathan [1 ]
Chan, Matthew [3 ,4 ]
Arasaratnam, Malmaruha [3 ,4 ]
机构：
[1] Univ New England, Armidale, NSW, Australia
[2] Gosford Hosp, Dept Radiat Oncol, Gosford, NSW, Australia
[3] Gosford Hosp, Dept Med Oncol, Gosford, NSW, Australia
[4] Wyong Hosp, Gosford, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [41] Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy
    Jimbo, Masaya
    Andrews, Jack R.
    Ahmed, Mohamed E.
    Dundar, Ayca
    Karnes, R. Jeffrey
    Bryce, Alan H.
    Kendi, Ayse T.
    Kwon, Eugene D.
    Lowe, Val J.
    Bold, Michael S.
    PROSTATE, 2022, 82 (01): : 41 - 48
  • [42] PROGNOSTIC ROLE OF [11C]CHOLINE PET/CT SCAN IN PATIENTS WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER UNDERGOING PRIMARY DOCETAXEL CHEMOTHERAPY
    Jimbo, Masaya
    Ahmed, Mohamed
    Andrews, Jack
    Alom, Manaf
    Dundar, Ayca
    Karnes, R. Jeffrey
    Bryce, Alan
    Kendi, Ayse
    Kwon, Eugene
    Bold, Michael
    JOURNAL OF UROLOGY, 2020, 203 : E565 - E566
  • [43] Impacts of sarcopenia with or without obesity on patients with gastric cancer
    Hao-Fan Wu
    Xian-Zhong Zhang
    Feng-Min Zhang
    Cheng-Le Zhuang
    Holistic Integrative Oncology, 3 (1):
  • [44] Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer
    Stéphanie Chemama
    Mohamed Amine Bayar
    Emilie Lanoy
    Samy Ammari
    Annabelle Stoclin
    Diane Goéré
    Dominique Elias
    Bruno Raynard
    Sami Antoun
    Annals of Surgical Oncology, 2016, 23 : 3891 - 3898
  • [45] Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer
    Chemama, Stephanie
    Bayar, Mohamed Amine
    Lanoy, Emilie
    Ammari, Samy
    Stoclin, Annabelle
    Goere, Diane
    Elias, Dominique
    Raynard, Bruno
    Antoun, Sami
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3891 - 3898
  • [46] Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer
    Kume, Haruki
    Kawai, Taketo
    Nagata, Masayoshi
    Azuma, Takeshi
    Miyazaki, Hideyo
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Homma, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 303 - 307
  • [47] Toxicity and Efficacy of Intermittent Docetaxel Chemotherapy for Hormone Refractory Prostate Cancer
    Olbert, P. J.
    Weil, C.
    Hegele, A.
    Hofmann, R.
    Schrader, A. J.
    AKTUELLE UROLOGIE, 2009, 40 (03) : 164 - 168
  • [48] Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer
    Safarinejad, MR
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (02) : 93 - 101
  • [49] Docetaxel and prostate cancer
    Ferrero, JM
    BULLETIN DU CANCER, 2004, 91 (02) : 172 - 177
  • [50] Docetaxel in prostate cancer
    Small, EJ
    ANTI-CANCER DRUGS, 2001, 12 : S17 - S20
12345